Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-02

Clinical Trial Update: Gabapentin for the Treatment of Tinnitus [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating gabapentin for tinnitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Tinnitus | Phase 2, Phase 3 | Status: TERMINATED